Childhood stage IV Hodgkin disease: Therapeutic results of the Polish Pediatric Leukemia/Lymphoma Study Group

Medical and Pediatric Oncology

Volumn 33, Issue 4, 1999, Pages 382-387

  Armata, Jerzy ^a   Balwierz, Walentyna ^a   Moryl Bujakowska, Angelina ^a   Bogusławska Jaworska, Janina ^b   Pisarek, Jolanta ^b   Soñta Jakimczyk, Danuta ^b   Janik Moszant, Anna ^b   Rokicka Milewska, Roma ^b   Sopyło, Barbara ^b   Kołakowska Mrozowska, Beatrycze ^b   Kołecki, Paweł ^b   Kaczmarek Kanold, Małgorzata ^b   Kowalczyk, Jerzy ^b   Skomra, Stanisław ^b   Matysiak, Michał ^b   Newecka Samól, Teresa ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b NONE

Author keywords

Chemotherapy combined with radiotherapy; Children; Hodgkin disease; Stage IV

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CHILD; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DACARBAZINE; DOXORUBICIN; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MECHLORETHAMINE; POLAND; PREDNISOLONE; PREDNISONE; PROCARBAZINE; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME; VINBLASTINE; VINCRISTINE;

EID: 0032872218     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199910)33:4<382::AID-MPO7>3.0.CO;2-7     Document Type: Article

References (42)

1. DeVita VT, Serpick A, Carbone PP. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 1970;73:881-895.
2. Freireich EJ, Henderson ES, Karon MR, Frei M. The treatment of acute leukemia considered with respect to cell population kinetics. In: The proliferation and spread of neoplastic cell. Baltimore: Williams and Wilkins; 1968. p 441-454.
3. Nicholson WM, Beard MEJ, Crowther D, et al. Combination chemotherapy in generalized Hodgkin's disease. Cancer 1970;3:7-10.
4. Bonadonna G, Valagusa P, Santoro A. Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. Ann Intern Med 1986;104:739-746.
5. Lokich JJ, Frei E, Jaffe N, Tullis J. New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's disease. Cancer 1976; 38:667-671.
6. Schellong G, Bramswig JH, Schwarze EW, Wannenmacher M, for the German Study Group on the Therapy of Childhood Hodgkin's Disease in the Deutsche Arbeitsgemeinschaft fur Leukamie-Forschung und -Behandlung im Kindersalter (DAL). An approach to reduce treatment and invasive staging in childhood Hodgkin's disease: the sequence of the German DAL multicenter studies. Bull Cancer 1988;75:41-51.
7. Connors J, Klimo P. MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease. Semin Hematol 1987;39:356-361.
8. Armata J, Balwierz W. Causes of treatment failure in Hodgkin's disease. Nowotwory 1996;46:346-353.
9. Longo DL. The case against the routine use of radiation therapy in advanced-stage Hodgkin's disease. Cancer Invest 1996;14:353-360.
10. Prosnitz LR, Wu JJ, Yahalom J. The case for adjuvant radiation therapy in advanced Hodgkin's disease. Cancer Invest 1996;14: 361-370.
11. Loeffler M, Brosteanu O, Hasenclever D, et al. Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. J Clin Oncol 1998;16:818-829.
12. Balwierz W, Armata J, Depowska T, et al. Results of chemotherapy combined with involved-field radiotherapy for children with Hodgkin's disease undergoing treatment in Report of the Polish Children's Leukemia/Lymphoma Study Group. Pediatr Pol 1994;59:721-728.
13. Balwierz W, Armata J, Depowska T, et al. Treatment results of children with Hodgkin's disease according to modified protocol introduced in 1994. Pediatr Pol 1997;72(Suppl 1):131-134.
14. Donaldson SS, Oberlin O. Hodgkin's disease. In: Voute PA, Barret A, Lemerle J, editors. Cancer in children. Clinical management. Berlin: Springer Verlag; 1992. p 150-151.
15. Hunger SP, Link MP, Donaldson SS. ABVD/MOPP and low-dose involved-field adiotherapy in pediatric Hodgkin's disease: the Stanford experience. J Clin Oncol 1994;12:2160-2166.
16. Jenkin D, Greenberg M, Fitzgerald A. A second malignant tumours in childhood Hodgkin's disease. Med Pediatr Oncol 1996; 26:373-379.
17. Lange BJ. Hodgkin's disease. In: D'Angio GJ, Sinniach D, Meadows AT. et al., editors. Practical pediatric oncology. London: Edward Arnold; 1992. p 261-266.
18. McClain KL, Heise R, Day DL, et al. Hodgkin's disease in children: correlation of characteristics, staging procedures, and treatment at the University of Minnesota. Am J Pediat Haematol Oncol 1990;12:147-154.
19. Oberlin O, Lewerger G, Pacquement H, et al. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: The experience of the French Society of Pediatric Oncology. J Clin Oncol 1992;10:1602-1608.
20. Schellong G, for the German-Austrian Pediatric Hodgkin's Disease Study Group. The balance between cure and late effects in childhood Hodgkin's lymphoma: the experience of the German-Austrian Study Group since 1978. Ann Oncol 1996;7(Suppl 4):S67-S72.
21. Vecchi V, Pileri S, Burneli R, et al. Treatment of pediatric Hodgkin's disease tailored to stage, mediastinal mass, and age. an Italian (AIEOP) Multicenter Study on 215 patients. Cancer 1993;71: 2049-2057.
22. Armata J, Stopyrowa J, Depowski M, et al. MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin's disease in children. Pol Tyg Lek 1975;30:885-990.
23. Balwierz W, Armata J, Moryl-Bujakowska A, et al. Chemotherapy combined with involved-field radiotherapy for 177 children with Hodgkin's disease treated in 1983-1987. Acta Paediatr Jpn 1991;33:703-708.
24. Balwierz W, Armata J, Tredowska-Skoczen, et al. Progression of Hodgkin' disease in children during primary combined modality treatment: how many patients can be cured by conventional therapy. Pediatr Rev Commun 1994;8:1-8.
25. Kaplan HJ, Meier P. Non-parametric estimation from incomplete observation. J Am Statist Assoc 1958;53:457-481.
26. Lobo-Sanahuja F, Garcia I, Barrantes JC, et al. Pediatric Hodgkin's disease in Costa Rica: twelve years' experience of primary treatment by chemotherapy alone, without staging laparotomy. Med Pediatr Oncol 1994;22:398-403.
27. Ertem U, Duru F, Dagdemir A, et al. Hodgkin's disease in 82 Turkish children diagnosed over a 10-year period: epidemiological, clinical, and histopathologic features and prognosis with prolonged chemotherapy. Pediatr Hemat Oncol 1997;14:359-366.
28. Leventhal BG, Donaldson SS. Hodgkin's disease. In: Pizzo PA, Poplack D, editors. Principles and practise of pediatric oncology. Philadelphia: J.B. Lippincott Company; 1989. p 457-476.
29. Harif M, Madani A, Guerbaoui M, et al. Childhood Hodgkin's disease in Casablanca/Morocco. XXVIIIth Meeting of the International Society of Pediatric Oncology: Oct. 1996, Vienna, Austria (abstract). Med Pediatr Oncol 1996;27:270.
30. Bader SB, Weinstein H, Mauch P, et al. Pediatric stage IV Hodgkin disease. Cancer 1993;72:249-255.
31. Armata J. Lymphocyte depletion Hodgkin's disease results from grossly delayed diagnosis. Lancet 1984;2:523.
32. Dionet C, Oberlin O, Habrand JL, et al. Initial chemotherapy and low-dose radiation in limited fields in childhood Hodgkin's disease: results of a joint cooperative study by the French Society of Pediatric Oncology (SFOP) and Hospital Saint-Luis, Paris. Int J Radiat Oncol Biol Phys 1988;15:341-346.
33. The International ChIVPP Treatment Group. ChIVPP therapy for Hodgkin's disease: experience of 960 patients. Ann Oncol 1995; 6:167-172.
34. Fryer CJ, Hutchinson RJ, Krailo M, et al. Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: a report from the Childrens Cancer Study Group. J Clin Oncol 1990; 8:1971-1980.
35. Behrendt H, Brinkuis M., Van Leeuven EF. Treatment Hodgkin's disease with ABVD without radiotherapy. Med Pediatr Oncol 1996;26:244-248.
36. Ekert H, Waters KD, Smith PJ, et al. Treatment with MOPP or ChIVPP chemotherapy only for all stages of childhood Hodgkin's disease. J Clin Oncol 1988;6:1845-1850.
37. Schellong G, Oberlin O, Riepenhausen M, et al. Stage IV childhood Hodgkin's disease (HD): Updated results of the SIOP Collaborative Study. XXIXth Meeting of the International Society of Pediatric Oncology 23-27 Sept. 1997, Instanbul, Turkey (abstract). Med Pediatr Oncol 1997;29:332.
38. Balwierz W, Armata J. Rationale for choice of combined modality treatment for childhood Hodgkin's disease by Polish Pediatric Leukemia/Lymphoma Study Group. Pediatr Pol 1996;71 (Suppl 1):27-30.
39. Carde P. Should poor risk patients with Hodgkin's disease be sorted out for intensive treatment? Leuk Lymph 1995;15 (Suppl 1):31-40.
40. Hesenclever D, Schmitz N, Diehl V. Is there a rationale for high-dose chemotherapy as first line treatment of advanced Hodgkin's disease? Leuk Lymph 1995;15(Suppl 1):47-49.
41. Raney RB. Hodgkin's disease in childhood: a review. J Pediat Hematol Oncol 1998;19:502-509.
42. Moreau P, Fleury J, Brice P. Early intensive therapy with autologous stem stem cell transplantation in advanced Hodgkin's disease: retrospective analysis of 158 cases from the French registry. Bone Marrow Transpl 1998;21:787-793.